Please Wait
Applying Filters...
menu
    • menu
    Chinese FDA-registered generic facilities gain steam, India maintains lead with 396 facilities

    Data Compilation
    #PharmaFlow

    Pipeline Prospector Nov 2024: Trump’s HHS pick drags down jab makers’ stocks; Novartis, Merck, Roche ink billion-dollar deals

    Stock Recap
    #PipelineProspector

    Menu

    Sevoflurane

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 77Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

    Last Updated on PharmaCompass Virtual Booth Country Registrant Name MF Registration No. Classification Initial Date of Reg. Latest Date of Reg. Registrant's Address
    26/09/2024 Central Glass Europe
    United Kingdom
    		 Central Glass Co., Ltd. 217MF10538 Sevoflurane 2005-09-09 2010-02-23 5253 Okiube, Ube City, Yamaguchi Prefecture
    26/09/2024 Jiangsu Hengrui Medicine
    China
    		 Jiangsu Hengrui Pharmaceuticals Co. , Ltd. 231MF10009 Sevoflurane “Hengrui” 2019-01-10 2019-01-10 No. 7, Kunlunshan Road, Economic and Technological Development Zone, Lianyungang, Jiangsu Province, P. R. China